GB2064336B - Device for dispensing medicaments - Google Patents

Device for dispensing medicaments

Info

Publication number
GB2064336B
GB2064336B GB8039174A GB8039174A GB2064336B GB 2064336 B GB2064336 B GB 2064336B GB 8039174 A GB8039174 A GB 8039174A GB 8039174 A GB8039174 A GB 8039174A GB 2064336 B GB2064336 B GB 2064336B
Authority
GB
United Kingdom
Prior art keywords
device
dispensing medicaments
medicaments
dispensing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8039174A
Other versions
GB2064336A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB7942208 priority Critical
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB8039174A priority patent/GB2064336B/en
Publication of GB2064336A publication Critical patent/GB2064336A/en
Application granted granted Critical
Publication of GB2064336B publication Critical patent/GB2064336B/en
Application status is Expired legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
GB8039174A 1979-12-06 1980-12-05 Device for dispensing medicaments Expired GB2064336B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB7942208 1979-12-06
GB8039174A GB2064336B (en) 1979-12-06 1980-12-05 Device for dispensing medicaments

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8039174A GB2064336B (en) 1979-12-06 1980-12-05 Device for dispensing medicaments
CY130880A CY1308A (en) 1979-12-06 1980-12-05 Device for dispensing medicaments

Publications (2)

Publication Number Publication Date
GB2064336A GB2064336A (en) 1981-06-17
GB2064336B true GB2064336B (en) 1984-03-14

Family

ID=26273811

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8039174A Expired GB2064336B (en) 1979-12-06 1980-12-05 Device for dispensing medicaments

Country Status (2)

Country Link
CY (1) CY1308A (en)
GB (1) GB2064336B (en)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1203660B (en) * 1982-10-08 1989-02-15 Glaxo Group Ltd Devices for administering drugs to patients and blister packaging for them
JPH0257942B2 (en) * 1986-12-05 1990-12-06 Kanto Ishi Pharma Co Ltd
GB9021433D0 (en) * 1990-10-02 1990-11-14 Atomic Energy Authority Uk Power inhaler
GB2253200A (en) * 1991-02-01 1992-09-02 Harris Pharma Ltd Inhalation apparatus and fracturable capsule for use therewith
GB9216038D0 (en) * 1992-07-28 1992-09-09 Bespak Plc Dispensing apparatus for powdered medicaments
DE4318455A1 (en) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg capsule holder
DE19835346A1 (en) 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Two-part capsule for holding pharmaceutical preparations for powder inhalers
OA12394A (en) 2000-08-05 2004-07-09 Glaxo Group Ltd 6.Alpha-,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fuoromethyl ester as an anti-inflammatory agent.
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0103630D0 (en) 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
EP1238680B1 (en) 2001-03-05 2003-12-10 Ivo Pera Inhaling device for dispersing powdered medicaments contained in a capsule through the respiratory tract
US7045658B2 (en) 2001-03-22 2006-05-16 Glaxo Group Limited Formailide derivatives as beta2-adrenoreceptor agonists
WO2002088167A1 (en) 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
SI2042168T1 (en) 2001-09-14 2014-01-31 Glaxo Group Limited Inhalation formulation comprising phenethanolamine derivatives for the treatment of respiratory diseases
USRE44874E1 (en) 2001-09-14 2014-04-29 Glaxo Group Limited Phenethanolamine derivatives for treatment of respiratory diseases
US8337816B2 (en) 2001-09-17 2012-12-25 Glaxo Group Limited Dry powder medicament formulations
DE60318193T2 (en) 2002-04-25 2008-12-04 Glaxo Group Ltd., Greenford Phenethanolaminderivate
GB0217225D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicinal compounds
CA2503588A1 (en) 2002-10-28 2004-05-06 Glaxo Group Limited Phenethanolamine derivative for the treatment of respiratory diseases
GB0303396D0 (en) 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
PE20050250A1 (en) 2003-07-17 2005-04-08 Glaxo Group Ltd Antagonists Muscarinic acetylcholine receptors
PL1677795T3 (en) 2003-10-14 2011-05-31 Glaxo Group Ltd Muscarinic acetycholine receptor antagonists
UY28567A1 (en) 2003-10-17 2005-05-31 Glaxo Group Ltd Antagonists of muscarinic acetylcholine receptors
TW200524577A (en) 2003-11-04 2005-08-01 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
DE10352277A1 (en) 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder inhaler
GB0329182D0 (en) 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
WO2005095407A1 (en) 2004-03-17 2005-10-13 Glaxo Group Limited M3 muscarinic acetylcholine receptor antagonists
US7846973B2 (en) 2004-04-02 2010-12-07 Theravance, Inc. Chemical process and new crystalline form
MY144753A (en) 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
US7598267B2 (en) 2004-05-13 2009-10-06 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
US7556035B2 (en) 2004-05-28 2009-07-07 Quadrant Technologies Limited Unit dose dry powder inhaler
DE102005001332A1 (en) 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Two-piece capsule with pre-closure for holding pharmaceutical preparations for powder inhalers
JP5156397B2 (en) 2005-02-10 2013-03-06 グラクソ グループ リミテッドGlaxo Group Limited Method for producing lactose using preclassification technology and pharmaceutical preparation formed from the lactose
MY145343A (en) 2005-03-25 2012-01-31 Glaxo Group Ltd Novel compounds
TW200724142A (en) 2005-03-25 2007-07-01 Glaxo Group Ltd Novel compounds
WO2007022351A2 (en) 2005-08-18 2007-02-22 Glaxo Group Limited Muscarinic acetylcholine receptor antagonists
PT103481B (en) 2006-05-16 2008-08-01 Hovione Farmaciencia S A Inhaler of simple use and inhalation method
PE20081889A1 (en) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indole carboxamides as inhibitors of IKK2
GB2463451A (en) 2008-09-08 2010-03-17 Cambridge Lab 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
EP2443134A2 (en) 2009-06-16 2012-04-25 Schering Corporation NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF
EP2611422B1 (en) 2010-08-31 2018-10-31 GlaxoSmithKline Intellectual Property Development Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
EP2611423B1 (en) 2010-08-31 2015-06-24 GlaxoSmithKline Intellectual Property Development Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
SG190793A1 (en) 2010-11-11 2013-07-31 Agency Science Tech & Res Targeting metabolic enzymes in human cancer
GB201116641D0 (en) 2011-09-27 2011-11-09 Glaxo Group Ltd Novel compounds
TWI593678B (en) 2012-04-27 2017-08-01 葛蘭素集團有限公司 Compounds useful as retinoid-related orphan receptor gamma (ror γ) modulators, the pharmaceutical compositions and use thereof
GB201207406D0 (en) 2012-04-27 2012-06-13 Glaxo Group Ltd Novel compounds
NZ708501A (en) 2012-11-28 2019-03-29 Intercept Pharmaceuticals Inc Treatment of pulmonary disease
KR20170123315A (en) 2015-03-11 2017-11-07 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Tslp binding protein
US10272095B2 (en) 2015-06-15 2019-04-30 GlaxoSmithKline Intellectual Propert Development Limited NRF2 regulators
CN107709306A (en) 2015-06-15 2018-02-16 葛兰素史密斯克莱知识产权发展有限公司 NRF2 conditioning agents
TW201722965A (en) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 Compounds for use in antibacterial applications
US10351530B2 (en) 2015-10-06 2019-07-16 Glaxosmithkline Intellectual Property Development Limited Arylcyclohexyl pyrazoles as NRF2 regulators
WO2017060854A1 (en) 2015-10-06 2017-04-13 Glaxosmithkline Intellectual Property Development Limited Biaryl pyrazoles as nrf2 regulators
TW201825458A (en) 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產(第二)有限公司 TRPV 4 antagonists
CA3036933A1 (en) 2016-09-20 2018-03-29 Glaxosmithkline Intellectual Property (No.2) Limited Trpv4 antagonists
US20190202784A1 (en) 2016-09-20 2019-07-04 Glaxosmithkline Intellectual Property (No.2) Limited Trpv4 antagonists
KR20190088404A (en) 2016-12-06 2019-07-26 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 3- (2,3-dihydro-1H-inden-5-yl) propanoic acid derivatives and their use as NRF2 regulators
EP3551620A1 (en) 2016-12-12 2019-10-16 GlaxoSmithKline Intellectual Property Development Limited 3-carboxylic acid pyrroles as nrf2 regulators
EP3551621A1 (en) 2016-12-12 2019-10-16 GlaxoSmithKline Intellectual Property Development Limited N-aryl pyrazoles as nrf2 regulators
WO2018109648A1 (en) 2016-12-14 2018-06-21 Glaxosmithkline Intellectual Property Development Limited 3-oxo-1,4-diazepinyle compounds as nrf2 activators
WO2018109647A1 (en) 2016-12-14 2018-06-21 Glaxosmithkline Intellectual Property Development Limited Bisaryl amides as nrf2 regulators
WO2018109643A1 (en) 2016-12-14 2018-06-21 Glaxosmithkline Intellectual Property Development Limited Bisaryl heterocycles as nrf2 acti
CA3044773A1 (en) 2016-12-15 2018-06-21 Glaxosmithkline Intellectual Property Development Limited Nrf2 activators
EP3555082A1 (en) 2016-12-15 2019-10-23 GlaxoSmithKline Intellectual Property Development Limited Ether linked triazoles as nrf2 regulators
WO2018200425A1 (en) 2017-04-24 2018-11-01 Cocrystal Pharma, Inc. Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
WO2019116230A1 (en) 2017-12-11 2019-06-20 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
WO2019116231A1 (en) 2017-12-11 2019-06-20 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
GB201720989D0 (en) 2017-12-15 2018-01-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
WO2019141694A1 (en) 2018-01-17 2019-07-25 Glaxosmithkline Intellectual Property Development Limited Pi4kiiibeta inhibitors
WO2019224667A1 (en) 2018-05-23 2019-11-28 Glaxosmithkline Intellectual Property Development Limited Indanes as nrf2 activators

Also Published As

Publication number Publication date
CY1308A (en) 1985-12-06
GB2064336A (en) 1981-06-17

Similar Documents

Publication Publication Date Title
GB2043766B (en) Liquid spraying device
DE3068054D1 (en) Simultaneous-analysis device
GB2004387B (en) Dosed delivery device for liquids
DE3273345D1 (en) Tablet dispensing device
DE3071938D1 (en) Dispenser for viscous or semi-viscous materials
GB2005141B (en) Liquid dispensing package
GB2054522B (en) Liquid dispensing system
DE3163728D1 (en) Dispensing device
GB2067863B (en) Weighing device
GB2056007B (en) Connecting device for iv administration set
GB2061228B (en) Dispensing container
EG14985A (en) Multipackaging device
GB2007626B (en) Dispensing apparatus
DE2965016D1 (en) System for dispensing fluid
YU101478A (en) Medicine delivering device
JPS55143143A (en) Ultrasoniccwave reflection device
IE49761B1 (en) Non-pressurized dispensing system
DE3071418D1 (en) Air dispensing apparatus
JPS5662501A (en) Tray device
JPS54144797A (en) Device for intaking powder medicine
GB2046354B (en) Metering apparatus
IE44963L (en) Dispenser device
IL58720D0 (en) Inhalation device
IL56482D0 (en) A tablet dispensing device
GB2040380B (en) Fluid dispensing system

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20001204